The funding from the UK Space Agency supports the establishment of a new advanced manufacturing facility in Gloucester.
"The opening of this manufacturing facility is a win for British ingenuity and a testament to our commitment to backing our homegrown space sector. The innovative technology developed here will support everything from our thriving satellite industry to future deep space missions."
The grant from the US Advanced Research Projects Agency for Health will support the POSEIDON programme for early oncology intervention.
"The field of cancer screening needs a revolution, and POSEIDON stands ready to deliver. The program allows for a better future by creating broadly accessible, at-home tests that will accurately detect 30+ cancers as early as Stage I, when tumours are still small and the chances of survival are high,"
The funding will support the development of the Callavid drug-device combination for threatened miscarriage.
"this new product will be extremely welcomed by miscarriage patients. Pessary leakage is a recurring issue amongst my patients, causing acute anxiety and significant inconvenience during a very difficult time."